holdFintel reports that on August 22, 2023, Cantor Fitzgerald...

hold

Fintel reports that on August 22, 2023, Cantor Fitzgerald coverage of AVITA Medical () with a Overweight recommendation.

Analyst Price Forecast Suggests 60.64% Upside

As of August 2, 2023, the average one-year for AVITA Medical is 26.26. The forecasts range from a low of 18.68 to a high of $42.00. The average price target represents an increase of 60.64% from its latest reported closing price of 16.35.

Pura Vida Investmentss 426K shares representing 0.33% ownership of the company. In it's prior filing, the firm reported owning 799K shares, representing a decrease of 87.40%. The firm decreased its portfolio allocation in RCEL by 14.98% over the last quarter.

VEXMX - Vanguard Extended Market Index Fund Investor Shares holds 344K shares representing 0.27% ownership of the company. In it's prior filing, the firm reported owning 340K shares, representing an increase of 1.21%. The firm increased its portfolio allocation in RCEL by 102.46% over the last quarter.

Millennium Management holds 274K shares representing 0.22% ownership of the company. In it's prior filing, the firm reported owning 335K shares, representing a decrease of 22.39%. The firm decreased its portfolio allocation in RCEL by 14.46% over the last quarter.

Additional reading:

What is the Fund Sentiment?

There are 131 funds or institutions reporting positions in AVITA Medical. This is an increase of 22 owner(s) or 20.18% in the last quarter. Average portfolio weight of all funds dedicated to RCEL is 0.03%, an increase of 26.25%. Total shares owned by institutions increased in the last three months by 32.77% to 7,741K shares. The put/call ratio of RCEL is 0.23, indicating a bullish outlook.

What are Other Shareholders Doing?

VTSMX - Vanguard Total Stock Market Index Fund Investor Sharesholds 816K shares representing 0.64% ownership of the company. In it's prior filing, the firm reported owning 756K shares, representing an increase of 7.40%. The firm increased its portfolio allocation in RCEL by 111.07% over the last quarter.

Geode Capital Management holds 475K shares representing 0.37% ownership of the company. In it's prior filing, the firm reported owning 250K shares, representing an increase of 47.37%. The firm increased its portfolio allocation in RCEL by 109.37% over the last quarter.